We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
One More Step to Finalize Your Registration
An activation link has been sent to your email address.
Please check the email and activate your account now. It might take few minutes to get the email.
If you did not find it, please check your spam box.
Having problem receiving the email? Send again
Still cannot receive? Contact us
Email ：PharmaSources@imsinoexpo.com
Whatsapp ：+86-13621645194
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,
Australasia,Asia,Middle East,Africa
Monthly Production Capacity: hundreds of grams
Packaging Information: 500mg,1g, 10g,50g 100g per package with icebag
Delivery Lead Time: In stock or 2-3 weeks
Sample Provided: yes
Payment Terms: T/T
Gramicidin A is an antibiotic produced by Bacillus brevis. It is a linear pentadecapeptide with N-terminal formylation blocking an amino group and C-terminal with an aldehyde group. Gramicidin A can kill some microorganisms. Two short Gramicidin A molecules are inserted relatively from both sides of the membrane to form a transmembrane channel, which improves the permeability of the biofilm to certain monovalent cations and allows these substances to pass through the cell membrane along the concentration gradient, but short Gramicidin A is not significant Increase transportation speed. Studies have shown that Gramicidin A can inhibit the transcription of T7 bacteriophage DNA, inhibit membrane-bound epidermal adenylate phosphatase activity and inhibit the transformation of human lymphocytes in vitro. It can prolong the survival rate of heart transplantation in rat animal models.
Audited Supplier
Pharma Sources Insight June 2024: Globalization on the Go
